{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:52:03Z","timestamp":1790092323859,"version":"4.0.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"DOI":"10.1038\/s41536-025-00445-8","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T06:19:30Z","timestamp":1767421170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity"],"prefix":"10.1038","volume":"11","author":[{"given":"Laura","family":"Palmieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Bimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Ferrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marcello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louna","family":"Pili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Vu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbass","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyad","family":"El-Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Brochier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Israeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-1004","authenticated-orcid":false,"given":"Sonia","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"445_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.23528","volume":"71","author":"JR Mendell","year":"2012","unstructured":"Mendell, J. R. et al. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann. Neurol. 71, 304\u2013313 (2012).","journal-title":"Ann. Neurol."},{"key":"445_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919\u2013928 (1987).","journal-title":"Cell"},{"key":"445_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti, J. M. & Campbell, K. P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809\u2013823 (1993).","journal-title":"J. Cell Biol."},{"key":"445_CR4","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710\u20133714 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1111\/febs.15466","volume":"287","author":"EP Hoffman","year":"2020","unstructured":"Hoffman, E. P. The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene. FEBS J. 287, 3879\u20133887 (2020).","journal-title":"FEBS J."},{"key":"445_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nrm2024","volume":"7","author":"KE Davies","year":"2006","unstructured":"Davies, K. E. & Nowak, K. J. Molecular mechanisms of muscular dystrophies: old and new players. Nat. Rev. Mol. Cell Biol. 7, 762\u2013773 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"445_CR7","doi-asserted-by":"crossref","unstructured":"Ennen, J. P., Verma, M. & Asakura, A. Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle 3, 9 (2013).","DOI":"10.1186\/2044-5040-3-9"},{"key":"445_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/hmg\/11.3.263","volume":"11","author":"JD Porter","year":"2002","unstructured":"Porter, J. D. et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum. Mol. Genet. 11, 263\u2013272 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"445_CR9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/jcsm.12708","volume":"12","author":"F Amor","year":"2021","unstructured":"Amor, F. et al. Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy. J. Cachexia Sarcopenia Muscle 12, 677\u2013693 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"445_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","volume":"29","author":"JR Mendell","year":"2021","unstructured":"Mendell, J. R. et al. duan. Mol. Ther. 29, 464\u2013488 (2021).","journal-title":"Mol. Ther."},{"key":"445_CR11","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14712598.2018.1479739","volume":"18","author":"S Aguti","year":"2018","unstructured":"Aguti, S., Malerba, A. & Zhou, H. The progress of AAV-mediated gene therapy in neuromuscular disorders. Expert Opin. Biol. Ther. 18, 681\u2013693 (2018).","journal-title":"Expert Opin. Biol. Ther."},{"key":"445_CR12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","volume":"26","author":"D Duan","year":"2018","unstructured":"Duan, D. Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy. Mol. Ther. 26, 2337\u20132356 (2018).","journal-title":"Mol. Ther."},{"key":"445_CR13","doi-asserted-by":"crossref","unstructured":"Le Guiner, C. et al. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Nat. Commun. 8, 16105 (2017).","DOI":"10.1038\/ncomms16105"},{"key":"445_CR14","doi-asserted-by":"publisher","first-page":"S303","DOI":"10.3233\/JND-210678","volume":"8","author":"N Elangkovan","year":"2021","unstructured":"Elangkovan, N. & Dickson, G. Gene therapy for Duchenne muscular dystrophy. J. Neuromuscul. Dis. 8, S303\u2013S316 (2021).","journal-title":"J. Neuromuscul. Dis."},{"key":"445_CR15","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nm0302-253","volume":"8","author":"SQ Harper","year":"2002","unstructured":"Harper, S. Q. et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med. 8, 253\u2013261 (2002).","journal-title":"Nat. Med."},{"key":"445_CR16","doi-asserted-by":"publisher","first-page":"13714","DOI":"10.1073\/pnas.240335297","volume":"97","author":"B Wang","year":"2000","unstructured":"Wang, B., Li, J. & Xiao, X. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc. Natl. Acad. Sci. USA 97, 13714\u201313719 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"445_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/hmg\/11.7.733","volume":"11","author":"SA Fabb","year":"2002","unstructured":"Fabb, S. A., Wells, D. J., Serpente, P. & Dickson, G. Adeno-associated virus vector gene transfer and sarcolemmal expression of a 144 kDa micro-dystrophin effectively restores the dystrophin-associated protein complex and inhibits myofibre degeneration in nude\/mdx mice. Hum. Mol. Genet. 11, 733\u2013741 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"445_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1089\/hum.2023.29242.ddu","volume":"34","author":"D Duan","year":"2023","unstructured":"Duan, D. Duchenne muscular dystrophy gene therapy in 2023: status, perspective, and beyond. Hum. Gene Ther. 34, 345\u2013349 (2023).","journal-title":"Hum. Gene Ther."},{"key":"445_CR19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"445_CR20","doi-asserted-by":"crossref","unstructured":"Tornabene, P. et al. Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina. Sci. Transl. Med. 11, eaav4523 (2019).","DOI":"10.1126\/scitranslmed.aav4523"},{"key":"445_CR21","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","volume":"165","author":"H Clevers","year":"2016","unstructured":"Clevers, H. Modeling development and disease with organoids. Cell 165, 1586\u20131597 (2016).","journal-title":"Cell"},{"key":"445_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","volume":"6","author":"M Hofer","year":"2021","unstructured":"Hofer, M. & Lutolf, M. P. Engineering organoids. Nat. Rev. Mater. 6, 402\u2013420 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"445_CR23","doi-asserted-by":"crossref","unstructured":"Garita-Hernandez, M. et al. AAV-mediated gene delivery to 3d retinal organoids derived from human induced pluripotent stem cells. Int. J. Mol. Sci. 21, 994 (2020).","DOI":"10.3390\/ijms21030994"},{"key":"445_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stemcr.2020.12.018","volume":"16","author":"K Kruczek","year":"2021","unstructured":"Kruczek, K. et al. Gene therapy of dominant CRX-leber congenital amaurosis using patient stem cell-derived retinal organoids. Stem Cell Rep. 16, 252\u2013263 (2021).","journal-title":"Stem Cell Rep."},{"key":"445_CR25","doi-asserted-by":"crossref","unstructured":"Khabou, H. et al. Noninvasive gene delivery to foveal cones for vision restoration. JCI Insight. 3, e96029 (2018).","DOI":"10.1172\/jci.insight.96029"},{"key":"445_CR26","doi-asserted-by":"crossref","unstructured":"Shin, M. K. et al. Generation of skeletal muscle organoids from human pluripotent stem cells to model myogenesis and muscle regeneration. Int. J. Mol. Sci. 23, 5108 (2022).","DOI":"10.3390\/ijms23095108"},{"key":"445_CR27","doi-asserted-by":"crossref","unstructured":"Pinton, L. et al. 3D human induced pluripotent stem cell-derived bioengineered skeletal muscles for tissue, disease and therapy modeling. Nat. Protoc. 18, 1337\u20131376 (2023).","DOI":"10.1038\/s41596-022-00790-8"},{"key":"445_CR28","doi-asserted-by":"crossref","unstructured":"Rao, L., Qian, Y., Khodabukus, A., Ribar, T. & Bursac, N. Engineering human pluripotent stem cells into a functional skeletal muscle tissue. Nat. Commun. 9, 126 (2018).","DOI":"10.1038\/s41467-017-02636-4"},{"key":"445_CR29","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/jcsm.13094","volume":"13","author":"M Shahriyari","year":"2022","unstructured":"Shahriyari, M. et al. Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy. J. Cachexia Sarcopenia Muscle 13, 3106\u20133121 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"445_CR30","doi-asserted-by":"crossref","unstructured":"Caputo, L. et al. Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGF\u03b2-dependent pro-fibrotic signaling. Skelet. Muscle 10, 13 (2020).","DOI":"10.1186\/s13395-020-00224-7"},{"key":"445_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.celrep.2013.02.012","volume":"3","author":"S Albini","year":"2013","unstructured":"Albini, S. et al. Epigenetic reprogramming of human embryonic stem cells into skeletal muscle cells and generation of contractile myospheres. Cell Rep. 3, 661\u2013670 (2013).","journal-title":"Cell Rep."},{"key":"445_CR32","doi-asserted-by":"crossref","unstructured":"Albini, S. & Puri, P. L. Generation of myospheres from hESCs by epigenetic reprogramming. J. Vis. Exp. e51243 (2014).","DOI":"10.3791\/51243-v"},{"key":"445_CR33","doi-asserted-by":"crossref","unstructured":"Iberite, F., Gruppioni, E. & Ricotti, L. Skeletal muscle differentiation of human iPSCs meets bioengineering strategies: perspectives and challenges. NPJ Regen. Med. 7, 23 (2022).","DOI":"10.1038\/s41536-022-00216-9"},{"key":"445_CR34","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1242\/dev.057463","volume":"138","author":"SJ Mathew","year":"2011","unstructured":"Mathew, S. J. et al. Connective tissue fibroblasts and Tcf4 regulate myogenesis. Development 138, 371\u2013384 (2011).","journal-title":"Development"},{"key":"445_CR35","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1016\/j.celrep.2018.11.092","volume":"25","author":"S Bersini","year":"2018","unstructured":"Bersini, S. et al. Engineering an environment for the study of fibrosis: A 3D human muscle model with endothelium specificity and endomysium. Cell Rep. 25, 3858\u20133868.e4 (2018).","journal-title":"Cell Rep."},{"key":"445_CR36","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4939-1047-2_15","volume":"1181","author":"M Tiburcy","year":"2014","unstructured":"Tiburcy, M., Meyer, T., Soong, P. L. & Zimmermann, W. H. Collagen-based engineered heart muscle. Methods Mol. Biol. 1181, 167\u2013176 (2014).","journal-title":"Methods Mol. Biol."},{"key":"445_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-012-9709-9","volume":"15","author":"N Rao","year":"2013","unstructured":"Rao, N. et al. Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices. Biomed. Microdevices 15, 161 (2013).","journal-title":"Biomed. Microdevices"},{"key":"445_CR38","doi-asserted-by":"crossref","unstructured":"Saleh, K. K. et al. Single cell sequencing maps skeletal muscle cellular diversity as disease severity increases in dystrophic mouse models. iScience 25, 105415 (2022).","DOI":"10.1016\/j.isci.2022.105415"},{"key":"445_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.molcel.2019.02.026","volume":"74","author":"L Giordani","year":"2019","unstructured":"Giordani, L. et al. High-dimensional single-cell cartography reveals novel skeletal muscle-resident cell populations. Mol. Cell 74, 609\u2013621.e6 (2019).","journal-title":"Mol. Cell"},{"key":"445_CR40","doi-asserted-by":"crossref","unstructured":"Petrany, M. J. et al. Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers. Nat. Commun. 11, 6374 (2020).","DOI":"10.1038\/s41467-020-20063-w"},{"key":"445_CR41","doi-asserted-by":"crossref","unstructured":"Karlsen, A. et al. Distinct myofibre domains of the human myotendinous junction revealed by single-nucleus RNA sequencing. J. Cell Sci. 136, jcs260913 (2023).","DOI":"10.1242\/jcs.260913"},{"key":"445_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ydbio.2011.03.015","volume":"354","author":"S Thorsteinsdottir","year":"2011","unstructured":"Thorsteinsdottir, S., Deries, M., Cacha\u00e7o, A. S. & Bajanca, F. The extracellular matrix dimension of skeletal muscle development. Dev. Biol. 354, 191\u2013207 (2011).","journal-title":"Dev. Biol."},{"key":"445_CR43","doi-asserted-by":"crossref","unstructured":"Costantini, M. et al. Biofabricating murine and human myo-substitutes for rapid volumetric muscle loss restoration. EMBO Mol. Med. 13, e12778 (2021).","DOI":"10.15252\/emmm.202012778"},{"key":"445_CR44","doi-asserted-by":"crossref","unstructured":"Al Tanoury, Z. et al. Prednisolone rescues Duchenne muscular dystrophy phenotypes in human pluripotent stem cell-derived skeletal muscle in vitro. Proc. Natl. Acad. Sci. USA 118, (2021).","DOI":"10.1073\/pnas.2022960118"},{"key":"445_CR45","doi-asserted-by":"crossref","unstructured":"Incitti, T. et al. Pluripotent stem cell-derived skeletal muscle fibers preferentially express myosin heavy-chain isoforms associated with slow and oxidative muscles. Skelet. Muscle 10, 17 (2020).","DOI":"10.1186\/s13395-020-00234-5"},{"key":"445_CR46","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7","volume":"50","author":"D Pette","year":"2000","unstructured":"Pette, D. & Staron, R. S. Myosin isoforms, muscle fiber types, and transitions. Microsc. Res. Tech. 50, 500\u2013509 (2000).","journal-title":"Microsc. Res. Tech."},{"key":"445_CR47","doi-asserted-by":"crossref","unstructured":"Minato, K. et al. Measurement of lateral transmission of force in the extensor digitorum longus muscle of young and old mice. Int. J. Mol. Sci. 22, 12356 (2021).","DOI":"10.3390\/ijms222212356"},{"key":"445_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00210-019-01727-x","volume":"393","author":"BR Erdogan","year":"2020","unstructured":"Erdogan, B. R. et al. Normalization of organ bath contraction data for tissue specimen size: does one approach fit all? Naunyn Schmiedebergs Arch. Pharm. 393, 243\u2013251 (2020).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"445_CR49","doi-asserted-by":"crossref","unstructured":"Santos, G. L. et al. Fibroblast derived human engineered connective tissue for screening applications. J. Vis. Exp. 2021 (2021).","DOI":"10.3791\/62700"},{"key":"445_CR50","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn, T. A. Cellular and molecular mechanisms of fibrosis J. Pathol. 214, 199\u2013210 (2008).","journal-title":"J. Pathol."},{"key":"445_CR51","doi-asserted-by":"publisher","first-page":"965631","DOI":"10.1155\/2014\/965631","volume":"2014","author":"Y Kharraz","year":"2014","unstructured":"Kharraz, Y., Guerra, J., Pessina, P., Serrano, A. L. & Mu\u00f1oz-C\u00e1noves, P. Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed. Res. Int. 2014, 965631 (2014).","journal-title":"Biomed. Res. Int."},{"key":"445_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-21","volume":"1","author":"CJ Mann","year":"2011","unstructured":"Mann, C. J. et al. Aberrant repair and fibrosis development in skeletal muscle. Skelet. Muscle 1, 21 (2011).","journal-title":"Skelet. Muscle"},{"key":"445_CR53","doi-asserted-by":"crossref","unstructured":"Kyrychenko, V. et al. Functional correction of dystrophin actin binding domain mutations by genome editing. JCI Insight 2, e95918 (2017).","DOI":"10.1172\/jci.insight.95918"},{"key":"445_CR54","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/apmr.2002.35109","volume":"83","author":"MK Childers","year":"2002","unstructured":"Childers, M. K. et al. Eccentric contraction injury in dystrophic canine muscle. Arch. Phys. Med Rehabil. 83, 1572\u20131578 (2002).","journal-title":"Arch. Phys. Med Rehabil."},{"key":"445_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18020647","volume":"18","author":"M Garc\u00eda-Sillero","year":"2021","unstructured":"Garc\u00eda-Sillero, M. et al. Comparison of interventional strategies to improve recovery after eccentric exercise-induced muscle fatigue. Int. J. Environ. Res. Public Health 18, 1\u201311 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"445_CR56","doi-asserted-by":"crossref","unstructured":"Hu, X. et al. A novel ex vivo protocol that mimics length and excitation changes of human muscles during walking induces force losses in EDL but not in soleus of mdx mice. PLoS One 20, e0320901 (2025).","DOI":"10.1371\/journal.pone.0320901"},{"key":"445_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1152\/physrev.00015.2007","volume":"88","author":"DG Allen","year":"2008","unstructured":"Allen, D. G., Lamb, G. D. & Westerblad, H. Skeletal muscle fatigue: Cellular mechanisms. Physiol. Rev. 88, 287\u2013332 (2008).","journal-title":"Physiol. Rev."},{"key":"445_CR58","doi-asserted-by":"crossref","unstructured":"Peczkowski, K. K. et al. Muscle twitch kinetics are dependent on muscle group, disease state, and age in Duchenne muscular dystrophy mouse models. Front. Physiol. 11, 568909 (2020).","DOI":"10.3389\/fphys.2020.568909"},{"key":"445_CR59","doi-asserted-by":"crossref","unstructured":"Klingberg, F. et al. The fibronectin ED-A domain enhances recruitment of latent TGF-\u03b2-binding protein-1 to the fibroblast matrix. J. Cell. Sci. 131, jcs201293 (2018)","DOI":"10.1242\/jcs.201293"},{"key":"445_CR60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00441-009-0889-4","volume":"339","author":"S Zanotti","year":"2010","unstructured":"Zanotti, S., Gibertini, S. & Mora, M. Altered production of extra-cellular matrix components by muscle-derived Duchenne muscular dystrophy fibroblasts before and after TGF-beta1 treatment. Cell Tissue Res. 339, 397\u2013410 (2010).","journal-title":"Cell Tissue Res."},{"key":"445_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","volume":"10","author":"KT Weber","year":"2013","unstructured":"Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A. & Gerling, I. C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 10, 15\u201326 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"445_CR62","doi-asserted-by":"publisher","first-page":"6484","DOI":"10.1111\/febs.16080","volume":"289","author":"G Giuliani","year":"2022","unstructured":"Giuliani, G., Rosina, M. & Reggio, A. Signaling pathways regulating the fate of fibro\/adipogenic progenitors (FAPs) in skeletal muscle regeneration and disease. FEBS J. 289, 6484\u20136517 (2022).","journal-title":"FEBS J."},{"key":"445_CR63","doi-asserted-by":"publisher","first-page":"814174","DOI":"10.3389\/fneur.2021.814174","volume":"12","author":"A Manini","year":"2021","unstructured":"Manini, A., Abati, E., Nuredini, A., Corti, S. & Comi, G.P. Adeno-associated virus (AAV)-mediated gene therapy for duchenne muscular dystrophy: the issue of transgene persistence. Front. Neurol. 12, 814174 (2021).","journal-title":"Front. Neurol."},{"key":"445_CR64","doi-asserted-by":"crossref","unstructured":"Pacak, C. A. et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3-9 (2006).","DOI":"10.1161\/01.RES.0000237661.18885.f6"},{"key":"445_CR65","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/hum.2019.173","volume":"31","author":"L Muraine","year":"2020","unstructured":"Muraine, L. et al. Transduction efficiency of adeno-associated virus serotypes after local injection in mouse and human skeletal muscle. Hum. Gene Ther. 31, 233\u2013240 (2020).","journal-title":"Hum. Gene Ther."},{"key":"445_CR66","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.RES.0000126574.61061.25","volume":"94","author":"KA Lapidos","year":"2004","unstructured":"Lapidos, K. A., Kakkar, R. & McNally, E. M. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ. Res. 94, 1023\u20131031 (2004).","journal-title":"Circ. Res."},{"key":"445_CR67","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1089\/ten.tea.2010.0700","volume":"17","author":"M Li","year":"2011","unstructured":"Li, M., Dickinson, C. E., Finkelstein, E. B., Neville, C. M. & Sundback, C. A. The role of fibroblasts in self-assembled skeletal muscle. Tissue Eng. Part A 17, 2641\u20132650 (2011).","journal-title":"Tissue Eng. Part A"},{"key":"445_CR68","doi-asserted-by":"crossref","unstructured":"Madden, L., Juhas, M., Kraus, W. E., Truskey, G. A. & Bursac, N. Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs. Elife 4, e04885 (2015).","DOI":"10.7554\/eLife.04885"},{"key":"445_CR69","doi-asserted-by":"publisher","unstructured":"Khodabukus, A. et al. Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle. Biomaterials https:\/\/doi.org\/10.1016\/j.biomaterials.2018.08.058 (2018).","DOI":"10.1016\/j.biomaterials.2018.08.058"},{"key":"445_CR70","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/jcsm.12527","volume":"11","author":"D Capitanio","year":"2020","unstructured":"Capitanio, D. et al. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients. J. Cachexia Sarcopenia Muscle 11, 547\u2013563 (2020).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"445_CR71","doi-asserted-by":"crossref","unstructured":"Heller, K. N., Mendell, J. T., Mendell, J. R. & Rodino-Klapac, L. R. MicroRNA-29 overexpression by adeno-associated virus suppresses fibrosis and restores muscle function in combination with micro-dystrophin. JCI Insight 2, e93309 (2017).","DOI":"10.1172\/jci.insight.93309"},{"key":"445_CR72","doi-asserted-by":"crossref","unstructured":"Hart, C. C. et al. Potential limitations of microdystrophin gene therapy for Duchenne muscular dystrophy. JCI Insight 9, e165869 (2024).","DOI":"10.1172\/jci.insight.165869"},{"key":"445_CR73","doi-asserted-by":"crossref","unstructured":"Desguerre, I. et al. Clinical heterogeneity of Duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One 4, e4347 (2009).","DOI":"10.1371\/journal.pone.0004347"},{"key":"445_CR74","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/nbm.3593","volume":"29","author":"TF Towse","year":"2016","unstructured":"Towse, T. F. et al. Post-contractile BOLD contrast in skeletal muscle at 7 T reveals inter-individual heterogeneity in the physiological responses to muscle contraction. NMR Biomed. 29, 1720\u20131728 (2016).","journal-title":"NMR Biomed."},{"key":"445_CR75","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.5966\/sctm.2014-0024","volume":"3","author":"C Badja","year":"2014","unstructured":"Badja, C. et al. Efficient and cost-effective generation of mature neurons from human induced pluripotent stem cells. Stem Cells Transl. Med. 3, 1467\u20131472 (2014).","journal-title":"Stem Cells Transl. Med."},{"key":"445_CR76","doi-asserted-by":"crossref","unstructured":"Tiburcy, M., Meyer, T., Liaw, N. Y. & Zimmermann, W. H. Generation of engineered human myocardium in a multi-well format. STAR Protoc. 1, 100032 (2020).","DOI":"10.1016\/j.xpro.2020.100032"},{"key":"445_CR77","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"445_CR78","doi-asserted-by":"crossref","unstructured":"Waisman, A., Norris, A. M., El\u00edas Costa, M. & Kopinke, D. Automatic and unbiased segmentation and quantification of myofibers in skeletal muscle. Sci. Rep. 11, 11793 (2021).","DOI":"10.1038\/s41598-021-91191-6"},{"key":"445_CR79","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"445_CR80","doi-asserted-by":"crossref","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"445_CR81","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"445_CR82","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."}],"updated-by":[{"DOI":"10.1038\/s41536-026-00474-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000}}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00445-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:03:28Z","timestamp":1776236608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-025-00445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1038\/s41536-025-00445-8","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41536-026-00474-x","URL":"https:\/\/doi.org\/10.1038\/s41536-026-00474-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}